Enzon Inc. of South Plainfield, N.J., completed its acquisition ofGenex Corp. after shareholders of the Gaithersburg, Md.,company voted to approve the deal.
Enzon will acquire all the outstanding shares of Genex stock(NASDAQ:GNEX) for about 701,000 common shares of Enzoncommon stock (NASDAQ:ENZN) and 583,000 three-yearwarrants to purchase one share of Enzon common stock at anexercise price of $18 per share. Enzon shares closed Thursdayat $11.35, up 38 cents.
Enzon said GenexLs specialty of genetic engineering andproduction of proteins fits EnzonLs goal of becoming a fullyintegrated protein drug developer.
(c) 1997 American Health Consultants. All rights reserved.